| 1029 | HSAP00P0000193496 | 0.4837 | 7.664 | 2.722 | 0.01521 | 0.1368 | -3.25 | CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | ENSG00000147889 | 151623, 155601, 155755, 600160, 606719 | 1029 | U26727 |
| 1063 | HSAP00P0000039978 | -0.9965 | 8.913 | -5.186 | 9.394e-05 | 0.01034 | 1.578 | CENPF | centromere protein F, 350/400kDa (mitosin) | ENSG00000117724 | 600236 | 1063 | NM_016343 |
| 2033 | HSAP00P0000417540 | -0.3535 | 8.841 | -1.575 | 0.1352 | 0.4115 | -5.18 | EP300 | E1A binding protein p300 | ENSG00000100393 | 114500, 180849, 602700, 613684 | 2033 | U01877 |
| 207 | HSAP00P0000298189 | -0.9794 | 9.721 | -6.253 | 1.226e-05 | 0.003417 | 3.512 | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ENSG00000142208 | 114480, 114500, 164730, 167000, 176920, 181500, 604370 | 207 | NM_005163 |
| 2175 | HSAP00P0000332717 | 0.7212 | 8.719 | 3.105 | 0.006901 | 0.09172 | -2.514 | FANCA | Fanconi anemia, complementation group A | ENSG00000187741 | 227650, 607139 | 2175 | NM_000135 |
| 2176 | HSAP00P0000199716 | 0.3492 | 5.889 | 1.843 | 0.08415 | 0.3248 | -4.783 | FANCC | Fanconi anemia, complementation group C | ENSG00000158169 | 227645, 227650, 613899 | 2176 | NM_000136 |
| 2885 | HSAP00P0000354324 | -0.4317 | 8.804 | -2.172 | 0.04544 | 0.2377 | -4.244 | GRB2 | growth factor receptor-bound protein 2 | ENSG00000177885 | 108355 | 2885 | AK024539 |
| 2886 | HSAP00P0000344234 | -0.6282 | 5.137 | -2.111 | 0.05107 | 0.2523 | -4.348 | GRB7 | growth factor receptor-bound protein 7 | ENSG00000141738 | 601522 | 2886 | NM_005310 |
| 3014 | HSAP00P0000251542 | -1.229 | 8.635 | -5.916 | 2.292e-05 | 0.004817 | 2.92 | H2AFX | H2A histone family, member X | ENSG00000188486 | 601772 | 3014 | NM_002105 |
| 3065 | HSAP00P0000010163 | -0.5626 | 10.6 | -2.45 | 0.02635 | 0.1806 | -3.754 | HDAC1 | histone deacetylase 1 | ENSG00000116478 | 601241 | 3065 | NM_004964 |
| 3066 | HSAP00P0000149822 | -1.16 | 8.656 | -4.966 | 0.0001457 | 0.01293 | 1.16 | HDAC2 | histone deacetylase 2 | ENSG00000196591 | 605164 | 3066 | NM_001527 |
| 3159 | HSAP00P0000141202 | -1.11 | 8.815 | -4.925 | 0.0001582 | 0.01352 | 1.081 | HMGA1 | high mobility group AT-hook 1 | ENSG00000137309 | 125853, 600701 | 3159 | AK130027 |
| 4691 | HSAP00P0000070997 | -2.037 | 8.67 | -6.743 | 5.056e-06 | 0.002161 | 4.344 | NCL | nucleolin | ENSG00000115053 | 164035 | 4691 | AK091742 |
| 4869 | HSAP00P0000130260 | -1.731 | 12.2 | -7.563 | 1.239e-06 | 0.001049 | 5.649 | NPM1 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) | ENSG00000181163 | 164040, 601626 | 4869 | AY347529 |
| 580 | HSAP00P0000068170 | -1.842 | 8.221 | -6.043 | 1.808e-05 | 0.004285 | 3.145 | BARD1 | BRCA1 associated RING domain 1 | ENSG00000138376 | 114480, 601593 | 580 | NM_000465 |
| 672 | HSAP00P0000346604 | -0.726 | 7.493 | -2.767 | 0.01386 | 0.1308 | -3.164 | BRCA1 | breast cancer 1, early onset | ENSG00000012048 | 113705, 114480, 604370 | 672 | AF005068 |